These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12617572)

  • 1. Anti-inflammatory effects of opioids.
    Walker JS
    Adv Exp Med Biol; 2003; 521():148-60. PubMed ID: 12617572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the hypothalamo-hypophyseal-adrenal axis to the anti-inflammatory actions of the kappa-opioid agonist PNU-50,488H in rats with adjuvant arthritis.
    Wilson JL; Carmody JJ; Walker JS
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1131-6. PubMed ID: 10945869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally acting opioids and clinical implications for pain control.
    Sehgal N; Smith HS; Manchikanti L
    Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides in experimental and degenerative arthritis.
    Niissalo S; Hukkanen M; Imai S; Törnwall J; Konttinen YT
    Ann N Y Acad Sci; 2002 Jun; 966():384-99. PubMed ID: 12114296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat.
    Walker JS; Scott C; Bush KA; Kirkham BW
    Neuropeptides; 2000; 34(3-4):193-202. PubMed ID: 11021980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and sensory nerves.
    Stein C; Zöllner C
    Handb Exp Pharmacol; 2009; (194):495-518. PubMed ID: 19655116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
    Binder W; Scott C; Walker JS
    Eur J Neurosci; 1999 Jun; 11(6):2065-72. PubMed ID: 10336675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids.
    Binder W; Carmody J; Walker J
    J Pharmacol Exp Ther; 2000 Jan; 292(1):303-9. PubMed ID: 10604963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.
    Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P
    Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral mechanisms of opioid analgesia.
    Stein C; Lang LJ
    Curr Opin Pharmacol; 2009 Feb; 9(1):3-8. PubMed ID: 19157985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological correlates of immune-mediated peripheral opioid analgesia.
    Mousa SA
    Adv Exp Med Biol; 2003; 521():77-87. PubMed ID: 12617566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
    Hua S; Cabot PJ
    Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental evidence for immunomodulatory effects of opioids.
    Sacerdote P; Limiroli E; Gaspani L
    Adv Exp Med Biol; 2003; 521():106-16. PubMed ID: 12617569
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid peptides in immune cells.
    Smith EM
    Adv Exp Med Biol; 2003; 521():51-68. PubMed ID: 12617564
    [No Abstract]   [Full Text] [Related]  

  • 17. Neural immune pathways and their connection to inflammatory diseases.
    Eskandari F; Webster JI; Sternberg EM
    Arthritis Res Ther; 2003; 5(6):251-65. PubMed ID: 14680500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling pain by influencing neurogenic pathways.
    Puehler W; Stein C
    Rheum Dis Clin North Am; 2005 Feb; 31(1):103-13, ix. PubMed ID: 15639058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: inhibition by kappa-opioid agonist but not by NSAID.
    Wilson JL; Walker JS; Antoon JS; Perry MA
    J Rheumatol; 1998 Mar; 25(3):499-505. PubMed ID: 9517771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.